Korro Bio Files Q1 2025 10-Q
Ticker: KRRO · Form: 10-Q · Filed: May 7, 2025 · CIK: 1703647
| Field | Detail |
|---|---|
| Company | Korro Bio, Inc. (KRRO) |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceutical
TL;DR
Korro Bio's Q1 2025 10-Q is in. Check financials and fair value disclosures.
AI Summary
Korro Bio, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Frequency Therapeutics, Inc., reported on its financial position and business operations. Key financial data points and disclosures related to fair value measurements and debt securities are included in this filing.
Why It Matters
This filing provides investors with an update on Korro Bio's financial health and operational status for the first quarter of 2025, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Korro Bio faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- 2834 — SIC Code (Standard Industrial Classification for Pharmaceutical Preparations)
- 001-39062 — SEC File Number (Korro Bio's SEC file number)
Key Players & Entities
- Korro Bio, Inc. (company) — Filer of the 10-Q
- Frequency Therapeutics, Inc. (company) — Former name of Korro Bio, Inc.
- 20250331 (date) — End of the reporting period
- 20250507 (date) — Filing date
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA 02141 (address) — Korro Bio's business and mailing address
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
What was Korro Bio, Inc. formerly known as?
Korro Bio, Inc. was formerly known as Frequency Therapeutics, Inc.
What is Korro Bio's business address?
Korro Bio's business address is 60 First Street, 2nd Floor, Suite 250, Cambridge, MA 02141.
What is the Standard Industrial Classification code listed for Korro Bio?
The Standard Industrial Classification code listed for Korro Bio is 2834, which corresponds to Pharmaceutical Preparations.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted to the SEC on May 7, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding Korro Bio, Inc. (KRRO).